Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cymabay Therapeutics Inc. (CBAY)

« Back to company index

CBAY Chatter Timeline

Stock Ticker for CBAY

Most Active Tweeters for CBAY

UserTweets
@ZolmaxNews 4
@dailypoliticaln 3
@gcassidy718 3
@AmericanBanking 3
@EnterpriseLeade 3

Recent Tweets for CBAY

AmericanBanking @AmericanBanking
Analysts Anticipate CymaBay Therapeutics Inc $CBAY to Post -$0.29 Earnings Per Share https://t.co/4DMeWlcj2G #stocks
April 2nd 2020, 9:04pm
gcassidy718 @gcassidy718
$CBAY definitely going to finish over $1.62 4.61 % change recently https://t.co/FJGm4Lzc67
April 2nd 2020, 7:04pm
OlympiaReport @OlympiaReport
CymaBay Therapeutics $CBAY Shares Down 5.4% https://t.co/kOWu1HQ8tU
March 27th 2020, 6:03pm
Tootix @Tootix
RT @GeryDIVRY: Despite their safety problems, $CBAY biopsies results are very good on NASH as predicted in my article 9 months ago https:/…
March 27th 2020, 8:03am
GeryDIVRY @GeryDIVRY
Despite their safety problems, $CBAY biopsies results are very good on NASH as predicted in my article 9 months ago… https://t.co/UrLU1Fgdg5
March 27th 2020, 7:03am
gcassidy718 @gcassidy718
$CBAY watching closely ... Over $1.71 this rips 9.93 % change recently https://t.co/FJGm4Lzc67
March 27th 2020, 1:03am
outsider_alerts @outsider_alerts
$CBAY - DROP x VOLUME ALERT - Price: 1.51, down -5.63% over prior 10 minute average, Volume: 138 x prior 10 minute average
March 25th 2020, 2:03pm
dailypoliticaln @dailypoliticaln
Analysts’ Weekly Ratings Updates for CymaBay Therapeutics $CBAY https://t.co/UqwgoJAVQK
March 25th 2020, 11:03am
ZolmaxNews @ZolmaxNews
Analysts’ Weekly Ratings Updates for CymaBay Therapeutics $CBAY https://t.co/Faa7ejDxGH
March 25th 2020, 11:03am
dispatchtribune @dispatchtribune
Analysts’ Weekly Ratings Updates for CymaBay Therapeutics $CBAY https://t.co/feR5FtCGwI
March 25th 2020, 11:03am
AmericanBanking @AmericanBanking
Analysts’ Weekly Ratings Updates for CymaBay Therapeutics $CBAY https://t.co/hZApkEj1vp #stocks
March 25th 2020, 11:03am
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics Inc Expected to Earn Q1 2020 Earnings of -$0.31 Per Share $CBAY https://t.co/1LQmAf6Ejc
March 25th 2020, 5:03am
dispatchtribune @dispatchtribune
CymaBay Therapeutics Inc Expected to Earn Q1 2020 Earnings of -$0.31 Per Share $CBAY https://t.co/iqKJIhlLwk
March 25th 2020, 5:03am
dailypoliticaln @dailypoliticaln
CymaBay Therapeutics Inc Expected to Earn Q1 2020 Earnings of -$0.31 Per Share $CBAY https://t.co/5bM7VAXecg
March 25th 2020, 5:03am
dakotafinancial @dakotafinancial
CymaBay Therapeutics Inc Expected to Earn Q1 2020 Earnings of -$0.31 Per Share $CBAY https://t.co/7i6t4bJLlS
March 25th 2020, 5:03am
gcassidy718 @gcassidy718
$CBAY sizable quote changes 5.15 % change recently https://t.co/FJGm4Lzc67
March 25th 2020, 1:03am
stocknewstimes @stocknewstimes
Brokerages Set CymaBay Therapeutics Inc $CBAY Price Target at $4.76 https://t.co/pknCk8LkE7
March 24th 2020, 6:03pm
WeekHerald @WeekHerald
Brokerages Set CymaBay Therapeutics Inc $CBAY Price Target at $4.76 https://t.co/qMVHbx9LEp
March 24th 2020, 6:03pm
WatchlistN @WatchlistN
CymaBay Therapeutics $CBAY PT Lowered to $1.60 at Citigroup https://t.co/yJx2PdX9ZS
March 24th 2020, 9:03am
ZolmaxNews @ZolmaxNews
Oppenheimer Brokers Increase Earnings Estimates for CymaBay Therapeutics Inc $CBAY https://t.co/YTG9f1NNVp
March 24th 2020, 5:03am
EnterpriseLeade @EnterpriseLeade
Oppenheimer Brokers Increase Earnings Estimates for CymaBay Therapeutics Inc $CBAY https://t.co/FPTel0VzWg
March 24th 2020, 5:03am
TheMarketsDaily @TheMarketsDaily
Oppenheimer Brokers Increase Earnings Estimates for CymaBay Therapeutics Inc $CBAY https://t.co/htVKm5RO5l
March 24th 2020, 5:03am
EnterpriseLeade @EnterpriseLeade
CymaBay Therapeutics $CBAY PT Lowered to $1.60 https://t.co/upxGFIziTE
March 23rd 2020, 6:03am
ThisLincolnian @ThisLincolnian
Citigroup Cuts CymaBay Therapeutics $CBAY Price Target to $1.60 https://t.co/s9RU1cgc5L
March 23rd 2020, 6:03am
ThisLincolnian @ThisLincolnian
Equities Analysts Issue Forecasts for CymaBay Therapeutics Inc’s Q1 2020 Earnings $CBAY https://t.co/2BKQ5UVtKC
March 23rd 2020, 1:03am
TickerReport @TickerReport
Equities Analysts Issue Forecasts for CymaBay Therapeutics Inc’s Q1 2020 Earnings $CBAY https://t.co/Xzt3zZtpVQ
March 23rd 2020, 1:03am
AmericanBanking @AmericanBanking
Equities Analysts Issue Forecasts for CymaBay Therapeutics Inc’s Q1 2020 Earnings $CBAY https://t.co/zBHUpWufqr #stocks
March 23rd 2020, 1:03am
dailypoliticaln @dailypoliticaln
B. Riley Lowers CymaBay Therapeutics $CBAY Price Target to $1.50 https://t.co/ICjLag7hH5
March 22nd 2020, 7:03am
ZolmaxNews @ZolmaxNews
B. Riley Lowers CymaBay Therapeutics $CBAY Price Target to $1.50 https://t.co/kCSfRLqh4s
March 22nd 2020, 7:03am
TheMarketsDaily @TheMarketsDaily
CymaBay Therapeutics Inc to Post FY2020 Earnings of -$0.88 Per Share, B. Riley Forecasts $CBAY https://t.co/yugrzgI8bu
March 22nd 2020, 2:03am
EnterpriseLeade @EnterpriseLeade
CymaBay Therapeutics Inc to Post FY2020 Earnings of -$0.88 Per Share, B. Riley Forecasts $CBAY https://t.co/Q2GZ8Ie460
March 22nd 2020, 2:03am
ZolmaxNews @ZolmaxNews
CymaBay Therapeutics Inc to Post FY2020 Earnings of -$0.88 Per Share, B. Riley Forecasts $CBAY https://t.co/nrJtgMNO2K
March 22nd 2020, 2:03am
grostz @grostz
@syinvesting $TORC and $CBAY would be great buys if they actually had a pipeline
March 21st 2020, 10:03am
TheMarketsDaily @TheMarketsDaily
CymaBay Therapeutics $CBAY PT Lowered to $1.50 at B. Riley https://t.co/zFidqBqwgI
March 21st 2020, 5:03am
dispatchtribune @dispatchtribune
B. Riley Lowers CymaBay Therapeutics $CBAY Price Target to $1.50 https://t.co/c3deZVUBcM
March 21st 2020, 5:03am
WatchlistN @WatchlistN
CymaBay Therapeutics $CBAY PT Lowered to $1.50 at B. Riley https://t.co/HkHefYzFij
March 21st 2020, 5:03am
TickerReport @TickerReport
B. Riley Weighs in on CymaBay Therapeutics Inc’s FY2020 Earnings $CBAY https://t.co/shNDBBSbnO
March 21st 2020, 4:03am
ThisLincolnian @ThisLincolnian
B. Riley Weighs in on CymaBay Therapeutics Inc’s FY2020 Earnings $CBAY https://t.co/oqHfDCgY0s
March 21st 2020, 4:03am
AmericanBanking @AmericanBanking
CymaBay Therapeutics Inc $CBAY Given Consensus Rating of “Hold” by Brokerages https://t.co/UuqEOUybMK #stocks
March 21st 2020, 4:03am
ZolmaxNews @ZolmaxNews
CymaBay Therapeutics Inc $CBAY to Post Q1 2020 Earnings of -$0.32 Per Share, B. Riley Forecasts https://t.co/2Rmmd0mtFf
March 21st 2020, 2:03am
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics Inc $CBAY to Post Q1 2020 Earnings of -$0.32 Per Share, B. Riley Forecasts https://t.co/p0Dp8gChSq
March 21st 2020, 2:03am
ConsumerFeed @ConsumerFeed
CymaBay Therapeutics Inc $CBAY to Post Q1 2020 Earnings of -$0.32 Per Share, B. Riley Forecasts https://t.co/kwq0xN68WA
March 21st 2020, 2:03am
TickerReport @TickerReport
CymaBay Therapeutics Inc $CBAY to Post Q1 2020 Earnings of -$0.32 Per Share, B. Riley Forecasts https://t.co/0AczUSBM9O
March 21st 2020, 2:03am
gcassidy718 @gcassidy718
$CBAY Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 7.25 % change recently https://t.co/FJGm4Lzc67
March 20th 2020, 9:03pm
AmericanBanking @AmericanBanking
CymaBay Therapeutics $CBAY Given New $1.60 Price Target at Citigroup https://t.co/FxxkGwPUkw #stocks
March 20th 2020, 12:03pm
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics $CBAY Given New $1.60 Price Target at Citigroup https://t.co/xPiKmEliq6
March 20th 2020, 11:03am
ConsumerFeed @ConsumerFeed
CymaBay Therapeutics $CBAY Given New $1.60 Price Target at Citigroup https://t.co/56Pc3j6IRi
March 20th 2020, 11:03am
dakotafinancial @dakotafinancial
CymaBay Therapeutics $CBAY Given New $1.60 Price Target at Citigroup https://t.co/L5AViGBbV0
March 20th 2020, 11:03am
BlueBioNow @BlueBioNow
$CBAY headed twds $1.50 . EOQ 8.80 % change recently https://t.co/5FMbJjXg5G
March 20th 2020, 11:03am
dakotafinancial @dakotafinancial
FY2020 EPS Estimates for CymaBay Therapeutics Inc Cut by B. Riley $CBAY https://t.co/ikwIMiERNY
March 20th 2020, 10:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.